F
Founda
Health Tech & Medtech · Amsterdam, Netherlands · Founded 2019
Enables healthcare to collaborate and innovate by offering a platform that exchanges data between healthcare IT systems and external applications MoreLess
Founda Health is a technology company specializing in healthcare integration solutions. The company operates in the healthcare sector, focusing on enabling digital transformation for healthcare providers, systems, and applications. Founda Health serves a diverse range of clients including hospitals, healthcare providers, IT teams, and digital health solution developers. The company offers a scalable API infrastructure that simplifies the integration of various healthcare applications, making it easier for healthcare providers to adopt new digital innovations. This infrastructure helps to streamline processes, improve patient care, and shift from reactive to proactive healthcare models. Founda Health's business model revolves around providing a platform that removes the barriers to digital innovation in healthcare, thereby facilitating faster and more efficient rollouts of new solutions. The company generates revenue through partnerships with healthcare applications and providers, who utilize their API to integrate and deliver their services more effectively.
Keywords: healthcare integration, API infrastructure, digital transformation, patient care, proactive healthcare, healthcare providers, digital health solutions, scalable platform, innovation, seamless integration.
Company overview
Founda company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Amsterdam, Netherlands
- Employees
- 91
- Open positions
- None listed
- Dealroom signal
- 77.4
- Investment activity
- 1 companies · latest Jan 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Founda funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Feb 2021 | $15M | $60M | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $7.1M | 0% | 91 |
| 2025 | $7.1M | 0% | 85 |
| 2024 | $7.1M | 0% | 74 |
| 2023 | $7.1M | 0% | 30 |
| 2022 | $7.1M | +129.7% | 51 |
| 2021 | $3.1M | +244.4% | 41 |
| 2020 | $900K | — | 16 |
Growth signals
Founda website traffic
Latest recorded traffic for Founda is 5.7K monthly website visits, up 0% over the last three months. Founda's team grew 7.1% over the past year.
Comparisons
Founda compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Founda investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Founda's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Founda's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Founda has talent and traffic
team presence
In the news
Latest news about Founda
Recent press, funding announcements, and product moves mentioning Founda — open to read from the original sources.
Market sentiment
What the market is saying about Founda
An AI-synthesized read of the highest-engagement posts about Founda on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Founda’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.